MedTrace Logo

Genicular Nerve Block in Juvenile Idiopathic Arthritis

NCT04687930 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2021-07-23

No results posted yet for this study

Summary

N=104 juvenile idiopathic arthritis patients diagnosed after ILAR criteria with unilateral persistent knee arthritis. They will be randomly assigned into two groups; group 1 will receive genicular nerve block, group 2 intra-articular triamcinolone. Both groups will be examined by SOLAR ultrasound scoring system, Visual analogue scale and Lysholm score at 0, 2 and 12 weeks. A semi-quantitative score will be used to assess tenderness and swelling at the same intervals.

Conditions

  • Juvenile Idiopathic Arthritis
  • Persistent Knee Arthritis
  • no Intra-articular Injection in the Last 3 Months
  • no Other Cause for Chronic Kneearthritis

Interventions

DRUG

genicular nerve block

nerve block of the genicular nerve at 3 points around the inflamed knee using ultrasound.

DRUG

intra-articular steroid injection

Triamcinilone injection into the knee joint under ultrasound guidance.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-02-15
Completion
2021-02-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04687930 on ClinicalTrials.gov